COVID-19 rapid test

for infectious diseasesfor antigensnasal

With excellent performance and results in just 5 minutes, the LumiraDx SARS-CoV-2 Ag Ultra test enables you to accurately and confidently test more patients, optimize clinic workflows and help triage patients without delay. Test benefits Microfluidic immunofluorescence assay Optimize clinical workflow Easy to implement at point of care No refrigeration storage required: room temperature storage (2-30°C) Small and portable Instrument Minimal handling steps Test workflow The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning correctly for every test run. The workflow process is comprised of a simple sample prep along with step-by-step guidance of the Instrument to report a patient result in under 5 minutes from sample application. Test performance In clinical studies, the LumiraDx SARS-CoV-2 Ag Ultra test demonstrated 97.4%* positive agreement versus RT-PCR from individuals with symptoms. High sensitivity in patients with a Ct value <34 within 12 days of the onset of symptoms – Rapidly identify potentially contagious spreaders. The following table shows the performance grouped by Ct value, illustrating that the LumiraDx SARS-CoV-2 Ag Ultra test has high sensitivity in patients with a Ct value <34. Samples with Cts above 33-34 are generally considered to be non-infectious1 indicating that the LumiraDx SARS-CoV-2 Ag Ultra test can rapidly identify potentially contagious spreaders.